Biotech Stocks Celegene, Gilead Could Boost IBB
April 06, 2017 at 10:54 AM EDT
The iShares Nasdaq Biotechnology ETF (NasdaqGM: IBB), the largest biotechnology exchange traded fund by assets, is up more than 10% year-to-date and some analysts believe some of the ETF’s marquee holdings have rebound potential, a scenario that could further boost IBB. IBB, which holds...